Our Translational Research Agreement (TRA) program provides support for non-clinical research projects.
Requests for materials transfer or sponsored research will be considered, with a limited number of projects supported each year. To discuss your proposed research or for questions about our process, please contact your regional Medical Science Liaison (MSL) or email us at email@example.com for help identifying the MSL in your region.
Project will be reviewed within 90 days and the regional MSL will present the proposal internally.
For questions regarding our process, email us at firstname.lastname@example.org.
Application and Questions
To apply for a TRA unrelated to enfortumab vedotin, register via our online portal.
To apply for a TRA related to enfortumab vedotin research, please visit the Astellas Investigator-Sponsored Research portal. Enfortumab vedotin proposals are reviewed jointly by Seagen and Astellas.
Please email email@example.com with questions about our TRA program.
Healthcare professionals in the United States can access recent congress presentations, videos about our science, and more on our medical affairs website.